Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 472021 - 472040 out of 476480 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
USA | (L01EG01) temsirolimus (adm: P) | TORISEL 25MG/ML INJ 1.8ML,VIAL | 1.8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Lymphoma, Mantle-Cell | Pfizer,Inc. |
USA | (L01EG02) everolimus (adm: O) | ZORTRESS 0.25MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | ZORTRESS 0.25MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | ZORTRESS 0.5MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | ZORTRESS 0.5MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | ZORTRESS 0.75MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | ZORTRESS 0.75MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | ZORTRESS 1MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | ZORTRESS 1MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | AFINITOR 10MG TABLET | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | AFINITOR 10MG TABLET | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | AFINITOR DISPERZ 2MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | AFINITOR DISPERZ 2MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | AFINITOR 2.5MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | AFINITOR 2.5MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | AFINITOR DISPERZ 3MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | AFINITOR DISPERZ 3MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | AFINITOR 5MG TABLET | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | AFINITOR 5MG TABLET | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
USA | (L01EG02) everolimus (adm: O) | AFINITOR DISPERZ 5MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |